SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-12-041316
Filing Date
2012-07-19
Accepted
2012-07-19 16:44:36
Documents
1
Period of Report
2012-07-09

Document Format Files

Seq Description Document Type Size
1 rrd351161.html 4/A  
1 rrd351161.xml 4/A 3996
  Complete submission text file 0001181431-12-041316.txt   5415
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 3530 TORINGDON WAY, SUITE 200 CHARLOTTE NC 28277
Business Address
Roberts Michael J (Reporting) CIK: 0001481629 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51462 | Film No.: 12970299